SUPN logo

Supernus Pharmaceuticals (SUPN) Interest expense

annual interest expense:

$0.00-$2.42M(-100.00%)
December 31, 2024

Summary

  • As of today (May 29, 2025), SUPN annual interest expense is $0.00, with the most recent change of -$2.42 million (-100.00%) on December 31, 2024.
  • During the last 3 years, SUPN annual interest expense has fallen by -$23.42 million (-100.00%).
  • SUPN annual interest expense is now -100.00% below its all-time high of $23.75 million, reached on December 31, 2020.

Performance

SUPN Interest expense Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSUPNincome statement metrics

quarterly interest expense:

N/A
March 31, 2025

Summary

  • SUPN quarterly interest expense is not available.

Performance

SUPN quarterly interest expense Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Range

Earnings dates

OtherSUPNincome statement metrics

TTM interest expense:

N/A
March 31, 2025

Summary

  • SUPN TTM interest expense is not available.

Performance

SUPN TTM interest expense Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Range

Earnings dates

OtherSUPNincome statement metrics

Interest expense Formula

Interest Expense = Carrying Value of Debt X Effective Interest Rate

SUPN Interest expense Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-100.0%--
3 y3 years-100.0%--
5 y5 years-100.0%--

SUPN Interest expense Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-100.0%at low
5 y5-year-100.0%at low
alltimeall time-100.0%at low

SUPN Interest expense History

DateAnnualQuarterlyTTM
Dec 2024
$0.00(-100.0%)
$0.00(0.0%)
$0.00(0.0%)
Sep 2024
-
$0.00(0.0%)
$0.00(0.0%)
Jun 2024
-
$0.00(0.0%)
$0.00(-100.0%)
Dec 2023
$2.42M(-65.8%)
$0.00(0.0%)
$2.42M(-39.8%)
Sep 2023
-
$0.00(-100.0%)
$4.01M(-30.1%)
Jun 2023
-
$910.00K(-39.5%)
$5.73M(-13.6%)
Mar 2023
-
$1.50M(-5.6%)
$6.63M(-6.2%)
Dec 2022
$7.07M(-69.8%)
$1.59M(-7.5%)
$7.07M(-38.0%)
Sep 2022
-
$1.72M(-4.8%)
$11.41M(-26.9%)
Jun 2022
-
$1.81M(-6.8%)
$15.61M(-19.0%)
Mar 2022
-
$1.94M(-67.3%)
$19.27M(-17.7%)
Dec 2021
$23.42M(-1.4%)
$5.93M(+0.2%)
$23.42M(-0.7%)
Sep 2021
-
$5.92M(+8.4%)
$23.59M(-0.7%)
Jun 2021
-
$5.47M(-10.3%)
$23.75M(-1.4%)
Mar 2021
-
$6.10M(+0.0%)
$24.10M(+1.4%)
Dec 2020
$23.75M(+4.6%)
$6.10M(+0.1%)
$23.75M(+1.4%)
Sep 2020
-
$6.09M(+4.7%)
$23.43M(+1.9%)
Jun 2020
-
$5.82M(+1.0%)
$23.01M(+1.9%)
Mar 2020
-
$5.75M(-0.4%)
$22.58M(-0.5%)
Dec 2019
$22.71M(+25.4%)
$5.78M(+2.0%)
$22.70M(+0.8%)
Sep 2019
-
$5.66M(+5.1%)
$22.52M(+0.4%)
Jun 2019
-
$5.39M(-8.2%)
$22.42M(-0.6%)
Mar 2019
-
$5.87M(+4.8%)
$22.56M(+24.6%)
Dec 2018
$18.11M(+1055.0%)
$5.60M(+0.6%)
$18.11M(+43.1%)
Sep 2018
-
$5.57M(+0.7%)
$12.66M(+74.7%)
Jun 2018
-
$5.53M(+289.8%)
$7.25M(+274.1%)
Mar 2018
-
$1.42M(+871.2%)
$1.94M(+23.5%)
Dec 2017
$1.57M
$146.00K(-5.8%)
$1.57M(-33.9%)
Sep 2017
-
$155.00K(-28.9%)
$2.37M(-30.7%)
DateAnnualQuarterlyTTM
Jun 2017
-
$218.00K(-79.2%)
$3.42M(-26.9%)
Mar 2017
-
$1.05M(+10.4%)
$4.68M(-8.0%)
Dec 2016
$5.09M(+6.7%)
$950.00K(-21.2%)
$5.09M(-5.3%)
Sep 2016
-
$1.21M(-18.3%)
$5.38M(-1.5%)
Jun 2016
-
$1.48M(+1.3%)
$5.46M(+7.3%)
Mar 2016
-
$1.46M(+18.0%)
$5.09M(+6.7%)
Dec 2015
$4.77M(-15.1%)
$1.24M(-4.2%)
$4.77M(-5.6%)
Sep 2015
-
$1.29M(+16.8%)
$5.05M(-6.0%)
Jun 2015
-
$1.10M(-3.2%)
$5.38M(-3.1%)
Mar 2015
-
$1.14M(-25.0%)
$5.55M(-1.2%)
Dec 2014
$5.62M(-28.4%)
$1.52M(-5.8%)
$5.62M(-9.4%)
Sep 2014
-
$1.61M(+26.4%)
$6.21M(-16.8%)
Jun 2014
-
$1.28M(+5.9%)
$7.46M(-10.4%)
Mar 2014
-
$1.21M(-42.7%)
$8.33M(+6.1%)
Dec 2013
$7.85M(+119.6%)
$2.11M(-26.6%)
$7.85M(+19.9%)
Sep 2013
-
$2.87M(+33.9%)
$6.54M(+43.7%)
Jun 2013
-
$2.14M(+194.9%)
$4.55M(+36.4%)
Mar 2013
-
$727.00K(-9.6%)
$3.34M(-6.6%)
Dec 2012
$3.58M(+91.6%)
$804.00K(-8.6%)
$3.58M(+9.0%)
Sep 2012
-
$880.00K(-5.3%)
$3.28M(+13.1%)
Jun 2012
-
$929.00K(-3.4%)
$2.90M(+17.4%)
Mar 2012
-
$962.00K(+89.0%)
$2.47M(+32.2%)
Dec 2011
$1.87M(>+9900.0%)
$509.00K(+2.0%)
$1.87M(-122.0%)
Sep 2011
-
$499.00K(0.0%)
-$8.47M(-5.6%)
Jun 2011
-
$499.00K(+38.6%)
-$8.97M(-5.3%)
Mar 2011
-
$360.00K(-103.7%)
-$9.47M(-3.7%)
Dec 2010
$0.00(0.0%)
-$9.83M(+6.7%)
-$9.83M(+6.7%)
Dec 2009
$0.00(-100.0%)
-$9.21M
-$9.21M
Dec 2008
$8.68M(>+9900.0%)
-
-
Dec 2007
$0.00
-
-

FAQ

  • What is Supernus Pharmaceuticals annual interest expense?
  • What is the all time high annual interest expense for Supernus Pharmaceuticals?
  • What is Supernus Pharmaceuticals annual interest expense year-on-year change?
  • What is the all time high quarterly interest expense for Supernus Pharmaceuticals?
  • What is the all time high TTM interest expense for Supernus Pharmaceuticals?

What is Supernus Pharmaceuticals annual interest expense?

The current annual interest expense of SUPN is $0.00

What is the all time high annual interest expense for Supernus Pharmaceuticals?

Supernus Pharmaceuticals all-time high annual interest expense is $23.75M

What is Supernus Pharmaceuticals annual interest expense year-on-year change?

Over the past year, SUPN annual interest expense has changed by -$2.42M (-100.00%)

What is the all time high quarterly interest expense for Supernus Pharmaceuticals?

Supernus Pharmaceuticals all-time high quarterly interest expense is $6.10M

What is the all time high TTM interest expense for Supernus Pharmaceuticals?

Supernus Pharmaceuticals all-time high TTM interest expense is $24.10M
On this page